Department of Thoracic Surgery, Tohoku University Hospital, Sendai, Japan.
Ann Thorac Surg. 2012 Apr;93(4):1061-8. doi: 10.1016/j.athoracsur.2012.01.004. Epub 2012 Mar 3.
In patients with completely resected non-small cell lung cancer, recurrence-free survival, postrecurrence survival, and metachronous primary lung cancer have not been well studied at the same time.
A total of 315 patients with non-small cell lung cancer who underwent complete resection between 2001 and 2005 were examined. Patients were routinely assessed with computed tomography of the chest and physical checkups every 4 months for the first 2 years and every 6 months from the third to the fifth year. After that, they were examined annually.
The overall 5-year survival was 70%. Of all 315 patients, 107 had recurrent disease. The median recurrence-free survival was 15.7 months. Multivariate analysis showed that pathologic stage and pleural invasion were associated with decreased recurrence-free survival. The median postrecurrence survival was 18.7 months. Multivariate analysis indicated that male sex, pleural invasion, extrathoracic recurrence, and supportive care for recurrence were associated with decreased postrecurrence survival. The cumulative rate of metachronous primary lung cancer at 5 years was 3.7%, and it developed even 8 years after the initial operation.
Only pleural invasion of the original lung cancer was related to both recurrence-free survival and postrecurrence survival. Moreover, postrecurrence survival was related to both site and treatment of the initial recurrence. The incidence of metachronous primary lung cancer was stable over time after the initial operation.
在完全切除的非小细胞肺癌患者中,无复发生存、复发后生存和同时性原发性肺癌尚未得到很好的研究。
共检查了 315 例 2001 年至 2005 年间行完全切除术的非小细胞肺癌患者。患者在最初的 2 年内每 4 个月进行一次胸部 CT 和体格检查,从第 3 年到第 5 年每 6 个月进行一次,之后每年进行一次。
总体 5 年生存率为 70%。在所有 315 例患者中,107 例出现疾病复发。无复发生存的中位时间为 15.7 个月。多变量分析表明,病理分期和胸膜侵犯与无复发生存时间缩短有关。复发后生存的中位时间为 18.7 个月。多变量分析表明,男性、胸膜侵犯、胸外复发和对复发的支持性治疗与复发后生存时间缩短有关。5 年内同时性原发性肺癌的累积发生率为 3.7%,甚至在初始手术后 8 年也会发生。
只有原发性肺癌的胸膜侵犯与无复发生存和复发后生存有关。此外,复发后生存与初始复发的部位和治疗有关。在初始手术后,同时性原发性肺癌的发生率随时间保持稳定。